Role of IL-1 in Poststroke Depressive-like Behavior in Mice

Biological Psychiatry

Volumn 60, Issue 8, 2006, Pages 812-818

  Craft, Tara K S ^a   DeVries, A Courtney ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Anhedonia; cytokines; glucocorticoids; IL 1 receptor antagonist; ischemia; middle cerebral artery occlusion

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METYRAPONE; MIFEPRISTONE; SUCROSE;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANNULATION; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION; STROKE; SUGAR INTAKE;

ANIMALS; ANTIMETABOLITES; CEREBROVASCULAR ACCIDENT; DEPRESSIVE DISORDER; DRINKING BEHAVIOR; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MALE; METYRAPONE; MICE; MICE, INBRED C57BL; MIFEPRISTONE; RECEPTORS, GLUCOCORTICOID; RECEPTORS, INTERLEUKIN-1; STROKE; SUCROSE;

EID: 33749505083     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.03.011     Document Type: Article

References (88)

1. Acalovschi D., Wiest T., Hartmann M., Farahmi M., Mansmann U., Auffarth G.U., et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34 (2003) 1864-1869
2. Angeleri F., Angeleri V.A., Foschi N., Giaquinto S., and Nolfe G. The influence of depression, social activity, and family stress on functional outcome after stroke. Stroke 24 (1993) 1478-1483
3. Anisman H., Hayley S., Turrin N., and Merali Z. Cytokines as a stressor: Implications for depressive illness. Int J Neuropsychopharmacol 5 (2002) 357-373
4. Anisman H., Kokkinidis L., and Merali Z. Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes. Brain Behav Immun 16 (2002) 544-556
5. Anisman H., and Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29 (2005) 525-546
6. Anisman H., Merali Z., Poulter M.O., and Hayley S. Cytokines as a precipitant of depressive illness: Animal and human studies. Curr Pharm Des 11 (2005) 963-972
7. Antonawich F.J., Miller G., Rigsby D.C., and Davis J.N. Regulation of ischemic cell death by glucocorticoids and adrenocorticotropic hormone. Neuroscience 88 (1999) 319-325
8. Arborelius L., Owens M.J., Plotsky P.M., and Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160 (1999) 1-12
9. Astrom M., Olsson T., and Asplund K. Different linkage of depression to hypercortisolism early versus late after stroke. A 3-year longitudinal study. Stroke 24 (1993) 52-57
10. Berg A., Palomaki H., Lehtihalmes M., Lonnqvist J., and Kaste M. Poststroke depression: An 18-month follow-up. Stroke 34 (2003) 138-143
11. Bluthe R.M., Dantzer R., and Kelley K.W. Central mediation of the effects of interleukin-1 on social exploration and body weight in mice. Psychoneuroendocrinology 22 (1997) 1-11
12. Bogousslavsky J. William Feinberg lecture 2002: Emotions, mood, and behavior after stroke. Stroke 34 (2003) 1046-1050
13. Capuron L., Hauser P., Hinze-Selch D., Miller A.H., and Neveu P.J. Treatment of cytokine-induced depression. Brain Behav Immun 16 (2002) 575-580
14. Carson A.J., MacHale S., Allen K., Lawrie S.M., Dennis M., House A., et al. Depression after stroke and lesion location: A systematic review. Lancet 356 (2000) 122-126
15. Castanon N., Leonard B.E., Neveu P.J., and Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav Immun 16 (2002) 569-574
16. Chemerinski E., and Robinson R.G. The neuropsychiatry of stroke. Psychosomatics 41 (2000) 5-14
17. Craft T.K., Glasper E.R., McCullough L., Zhang N., Sugo N., Otsuka T., et al. Social interaction improves experimental stroke outcome. Stroke 36 (2005) 2006-2011
18. Dantzer R., Wollman E.E., Vitkovic L., and Yirmiya R. Cytokines, stress, and depression. Conclusions and perspectives. Adv Exp Med Biol 461 (1999) 317-329
19. DeGraba T.J. The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy. Neurology 51 (1998) S62-S68
20. De La Garza II R. Endotoxin- or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: Focus on anhedonia. Neurosci Biobehav Rev 29 (2005) 761-770
21. DeVries A.C., Joh H.D., Bernard O., Hattori K., Hurn P.D., Traystman R.J., et al. Social stress exacerbates stroke outcome by suppressing Bcl-2 expression. Proc Natl Acad Sci U S A 98 (2001) 11824-11828
22. DeVries A.C., Nelson R.J., Traystman R.J., and Hurn P.D. Cognitive and behavioral assessment in experimental stroke research: Will it prove useful?. Neurosci Biobehav Rev 25 (2001) 325-342
23. Douma B.R., Korte S.M., Buwalda B., la Fleur S.E., Bohus B., and Luiten P.G. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning. Psychoneuroendocrinology 23 (1998) 33-44
24. Dunn A.J., Swiergiel A.H., and de Beaurepaire R. Cytokines as mediators of depression: What can we learn from animal studies?. Neurosci Biobehav Rev 29 (2005) 891-909
25. Fassbender K., Schmidt R., Mossner R., Daffertshofer M., and Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 25 (1994) 1105-1108
26. Ferrarese C., Mascarucci P., Zoia C., Cavarretta R., Frigo M., Begni B., et al. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab 19 (1999) 1004-1009
27. Folstein M.F., Maiberger R., and McHugh P.R. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 40 (1977) 1018-1020
28. Gao M.X., Li K., Dong J., Liege S., Jiang B., and Neveu P.J. Strain-dependent association between lateralization and lipopolysaccharide- induced IL-1beta and IL-6 production in mice. Neuroimmunomodulation 8 (2000) 78-82
29. Garcia J.H., Liu K.F., and Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol 147 (1995) 1477-1486
30. Gill R., Sibson N.R., Hatfield R.H., Burdett N.G., Carpenter T.A., Hall L.D., et al. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J Cereb Blood Flow Metab 15 (1995) 1-11
31. Grippo A.J., Francis J., Beltz T.G., Felder R.B., and Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav 84 (2005) 697-706
32. Gupta A., Pansari K., and Shetty H. Post-stroke depression. Int J Clin Pract 56 (2002) 531-537
33. Hachinski V. Post-stroke depression, not to be underestimated. Lancet 353 (1999) 1728
34. Hattori K., Lee H., Hurn P.D., Crain B.J., Traystman R.J., and DeVries A.C. Cognitive deficits after focal cerebral ischemia in mice. Stroke 31 (2000) 1939-1944
35. Hill J.K., Gunion-Rinker L., Kulhanek D., Lessov N., Kim S., Clark W.M., et al. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Res 820 (1999) 45-54
36. Holsboer F., and Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 17 (1996) 187-205
37. Johansson A., Olsson T., Carlberg B., Karlsson K., and Fagerlund M. Hypercortisolism after stroke-partly cytokine-mediated?. J Neurol Sci 147 (1997) 43-47
38. Langer S.L., Pettigrew L.C., Wilson J.F., and Blonder L.X. Personality and social competency following unilateral stroke. J Int Neuropsychol Soc 4 (1998) 447-455
39. Legos J.J., Whitmore R.G., Erhardt J.A., Parsons A.A., Tuma R.F., and Barone F.C. Quantitative changes in interleukin proteins following focal stroke in the rat. Neurosci Lett 282 (2000) 189-192
40. Leonard B.E., and Song C. Changes in the immune system in rodent models of depression. Int J Neuropsychopharmacol 5 (2002) 345-356
41. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4 (1999) 317-327
42. May M., McCarron P., Stansfeld S., Ben-Shlomo Y., Gallacher J., Yarnell J., et al. Does psychological distress predict the risk of ischemic stroke and transient ischemic attack?. The Caerphilly Study. Stroke 33 (2002) 7-12
43. Merali Z., Brennan K., Brau P., and Anisman H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: Antidepressant and gender effects on responding for "free chow" and "earned" sucrose intake. Psychopharmacology (Berl) 165 (2003) 413-418
44. Miller A.H., Pariante C.M., and Pearce B.D. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 461 (1999) 107-116
45. Mulcahy N.J., Ross J., Rothwell N.J., and Loddick S.A. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 140 (2003) 471-476
46. Musselman D.L., Miller A.H., Porter M.R., Manatunga A., Gao F., Penna S., et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. Am J Psychiatry 158 (2001) 1252-1257
47. Musselman D.L., and Nemeroff C.B. Depression and endocrine disorders: Focus on the thyroid and adrenal system. Br J Psychiatry Suppl (1996) 123-128
48. Narushima K., Kosier J.T., and Robinson R.G. A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 15 (2003) 422-430
49. Neau J.P., Ingrand P., Mouille-Brachet C., Rosier M.P., Couderq C., Alvarez A., et al. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 8 (1998) 296-302
50. Neigh G.N., Kofler J., Meyers J.L., Bergdall V., La Perle K.M., Traystman R.J., et al. Cardiac arrest/cardiopulmonary resuscitation increases anxiety-like behavior and decreases social interaction. J Cereb Blood Flow Metab 24 (2004) 372-382
51. Neveu P.J., Bluthe R.M., Liege S., Moya S., Michaud B., and Dantzer R. Interleukin-1-induced sickness behavior depends on behavioral lateralization in mice. Physiol Behav 63 (1998) 587-590
52. Piamarta F., Iurlaro S., Isella V., Atzeni L., Grimaldi M., Russo A., et al. Unconventional affective symptoms and executive functions after stroke in the elderly. Arch Gerontol Geriatr Suppl 9 (2004) 315-323
53. Pohjasvaara T., Leppavuori A., Siira I., Vataja R., Kaste M., and Erkinjuntti T. Frequency and clinical determinants of poststroke depression. Stroke 29 (1998) 2311-2317
54. Pollak Y., and Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for "depression due to a general medical condition", immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5 (2002) 389-399
55. Raison C.L., and Miller A.H. The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry 6 (2001) 277-294
56. Rami A., Rabie A., and Winckler J. Synergy between chronic corticosterone treatment and cerebral ischemia in producing damage in noncalbindinergic neurons. Exp Neurol 149 (1998) 439-446
57. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29 (1992) 243-246
58. Risedal A., Nordborg C., and Johansson B.B. Infarct volume and functional outcome after pre- and postoperative administration of metyrapone, a steroid synthesis inhibitor, in focal brain ischemia in the rat. Eur J Neurol 6 (1999) 481-486
59. Robinson R.G. Poststroke depression: Prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 54 (2003) 376-387
60. Robinson R.G., Kubos K.L., Starr L.B., Rao K., and Price T.R. Mood disorders in stroke patients. Importance of location of lesion. Brain 107 (1984) 81-93
61. Rothwell N., Allan S., and Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: Pathophysiological and therapeutic implications. J Clin Invest 100 (1997) 2648-2652
62. Rothwell N.J., and Luheshi G.N. Interleukin 1 in the brain: Biology, pathology and therapeutic target. Trends Neurosci 23 (2000) 618-625
63. Rotllant D., and Armario A. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroscience 130 (2005) 427-434
64. Rotllant D., Ons S., Carrasco J., and Armario A. Evidence that metyrapone can act as a stressor: effect on pituitary-adrenal hormones, plasma glucose and brain c-fos induction. Eur J Neurosci 16 (2002) 693-700
65. Schubert D.S., Taylor C., Lee S., Mentari A., and Tamaklo W. Detection of depression in the stroke patient. Psychosomatics 33 (1992) 290-294
66. Schwartz J.A., Speed N.M., Brunberg J.A., Brewer T.L., Brown M., and Greden J.F. Depression in stroke rehabilitation. Biol Psychiatry 33 (1993) 694-699
67. Segreti J., Gheusi G., Dantzer R., Kelley K.W., and Johnson R.W. Defect in interleukin-1beta secretion prevents sickness behavior in C3H/HeJ mice. Physiol Behav 61 (1997) 873-878
68. Sharpe M., Hawton K., House A., Molyneux A., Sandercock P., Bamford J., et al. Mood disorders in long-term survivors of stroke: Associations with brain lesion location and volume. Psychol Med 20 (1990) 815-828
69. Shima S. The efficacy of antidepressants in post-stroke depression. Keio J Med 46 (1997) 25-26
70. Slowik A., Turaj W., Pankiewicz J., Dziedzic T., Szermer P., and Szczudlik A. Hypercortisolemia in acute stroke is related to the inflammatory response. J Neurol Sci 196 (2002) 27-32
71. Smith-Swintosky V.L., Pettigrew L.C., Sapolsky R.M., Phares C., Craddock S.D., Brooke S.M., et al. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Metab 16 (1996) 585-598
72. Soulet D., and Rivest S. Polyamines play a critical role in the control of the innate immune response in the mouse central nervous system. J Cell Biol 162 (2003) 257-268
73. Starkstein S.E., and Robinson R.G. Depression following cerebrovascular lesions. Semin Neurol 10 (1990) 247-253
74. Stenzel-Poore M.P., Cameron V.A., Vaughan J., Sawchenko P.E., and Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130 (1992) 3378-3386
75. Stout S.C., Mortas P., Owens M.J., Nemeroff C.B., and Moreau J. Increased corticotropin-releasing factor concentrations in the bed nucleus of the stria terminalis of anhedonic rats. Eur J Pharmacol 401 (2000) 39-46
76. Sugo N., Hurn P.D., Morahan M.B., Hattori K., Traystman R.J., and DeVries A.C. Social stress exacerbates focal cerebral ischemia in mice. Stroke 33 (2002) 1660-1664
77. Szczudlik A., Dziedzic T., Bartus S., Slowik A., and Kieltyka A. Serum interleukin-6 predicts cortisol release in acute stroke patients. J Endocrinol Invest 27 (2004) 37-41
78. Tarkowski E., Blomstrand C., and Tarkowski A. Stroke induced lateralization of delayed-type hypersensitivity in the early and chronic phase of the disease: A prospective study. J Clin Lab Immunol 46 (1995) 73-83
79. Tarkowski E., Ekelund P., and Tarkowski A. Enhancement of antigen-specific T-cell reactivity on the affected side in stroke patients. J Neuroimmunol 34 (1991) 61-67
80. Tarkowski E., Jensen C., Ekholm S., Ekelund P., Blomstrand C., and Tarkowski A. Localization of the brain lesion affects the lateralization of T-lymphocyte dependent cutaneous inflammation. Evidence for an immunoregulatory role of the right frontal cortex-putamen region. Scand J Immunol 47 (1998) 30-36
81. Tarkowski E., Naver H., Wallin B.G., Blomstrand C., and Tarkowski A. Lateralization of T-lymphocyte responses in patients with stroke. Effect of sympathetic dysfunction?. Stroke 26 (1995) 57-62
82. Tarkowski E., Rosengren L., Blomstrand C., Wikkelso C., Jensen C., Ekholm S., et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26 (1995) 1393-1398
83. Whyte E.M., Mulsant B.H., Vanderbilt J., Dodge H.H., and Ganguli M. Depression after stroke: A prospective epidemiological study. J Am Geriatr Soc 52 (2004) 774-778
84. Williams L.S., Ghose S.S., and Swindle R.W. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry 161 (2004) 1090-1095
85. Willner P., Muscat R., and Papp M. Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev 16 (1992) 525-534
86. Wright C.E., Strike P.C., Brydon L., and Steptoe A. Acute inflammation and negative mood: Mediation by cytokine activation. Brain Behav Immun 19 (2005) 345-350
87. Yang G.Y., Zhao Y.J., Davidson B.L., and Betz A.L. Overexpression of interleukin-1 receptor antagonist in the mouse brain reduces ischemic brain injury. Brain Res 751 (1997) 181-188
88. Zhai Q.H., Futrell N., and Chen F.J. Gene expression of IL-10 in relationship to TNF-alpha, IL-1beta and IL-2 in the rat brain following middle cerebral artery occlusion. J Neurol Sci 152 (1997) 119-124